HIAHX: Hartford Healthcare HLS IA

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

HIAHX Hartford Healthcare HLS IA


Profile

HIAHX - Profile

Vitals

  • YTD Return -11.5%
  • 3 Yr Annualized Return -4.5%
  • 5 Yr Annualized Return -8.6%
  • Net Assets $195 M
  • Holdings in Top 10 35.3%

52 WEEK LOW AND HIGH

$20.95
$17.54
$24.58

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.91%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 42.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return -11.5%
  • 3 Yr Annualized Total Return 0.6%
  • 5 Yr Annualized Total Return 1.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.11%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Hartford Healthcare HLS Fund
  • Fund Family Name
    Hartford Mutual Funds
  • Inception Date
    May 01, 2000
  • Shares Outstanding
    N/A
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Ann Gallo

Fund Description

The fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser. It will invest in securities of issuers located in a number of different countries throughout the world, one of which may be the United States; however, it has no limit on the amount of assets that may be invested in each country. The fund may invest in securities of companies of any market capitalization.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Performance

HIAHX - Performance

Return Ranking - Trailing

Period HIAHX Return Category Return Low Category Return High Rank in Category (%)
YTD -11.5% -29.6% 0.0% 73.08%
1 Yr -12.2% -34.1% 18.7% 85.59%
3 Yr -4.5%* -14.6% 13.6% 90.09%
5 Yr -8.6%* -12.9% 6.4% 90.20%
10 Yr 4.1%* -4.0% 13.2% 61.90%

* Annualized

Return Ranking - Calendar

Period HIAHX Return Category Return Low Category Return High Rank in Category (%)
2019 15.1% 5.7% 55.4% 76.07%
2018 -8.5% -25.3% 21.5% 61.26%
2017 4.7% -10.8% 43.9% 86.24%
2016 -29.2% -31.6% 6.9% 98.11%
2015 1.0% -20.4% 13.8% 22.77%

Total Return Ranking - Trailing

Period HIAHX Return Category Return Low Category Return High Rank in Category (%)
YTD -11.5% -29.6% 0.0% 73.08%
1 Yr -12.2% -34.1% 18.7% 85.59%
3 Yr 0.6%* -14.6% 16.5% 63.06%
5 Yr 1.6%* -12.9% 11.2% 37.25%
10 Yr 11.5%* -4.0% 15.7% 36.90%

* Annualized

Total Return Ranking - Calendar

Period HIAHX Return Category Return Low Category Return High Rank in Category (%)
2019 15.1% 5.7% 55.4% 76.07%
2018 -8.5% -25.3% 22.2% 64.86%
2017 22.4% -10.8% 45.8% 31.19%
2016 -8.7% -26.4% 8.7% 28.30%
2015 13.1% -16.6% 15.2% 6.93%

NAV & Total Return History


Holdings

HIAHX - Holdings

Concentration Analysis

HIAHX Category Low Category High HIAHX % Rank
Net Assets 195 M 1.6 M 41.3 B 71.54%
Number of Holdings 110 26 390 22.31%
Net Assets in Top 10 75.2 M 141 K 19.7 B 74.62%
Weighting of Top 10 35.28% 21.6% 76.3% 63.85%

Top 10 Holdings

  1. Pfizer Inc 5.03%
  2. Bristol-Myers Squibb Company 4.29%
  3. Abbott Laboratories 4.19%
  4. Medtronic PLC 3.88%
  5. Eli Lilly and Co 3.60%
  6. Thermo Fisher Scientific Inc 3.43%
  7. UnitedHealth Group Inc 2.87%
  8. Boston Scientific Corp 2.85%
  9. Danaher Corp 2.61%
  10. Anthem Inc 2.55%

Asset Allocation

Weighting Return Low Return High HIAHX % Rank
Stocks
98.91% 58.15% 102.77% 31.54%
Cash
1.09% -0.01% 41.85% 60.00%
Preferred Stocks
0.00% 0.00% 1.02% 76.92%
Other
0.00% -2.77% 7.62% 78.46%
Convertible Bonds
0.00% 0.00% 0.40% 72.31%
Bonds
0.00% -0.01% 14.94% 75.38%

Stock Sector Breakdown

Weighting Return Low Return High HIAHX % Rank
Healthcare
100.00% 61.99% 100.00% 40.77%
Utilities
0.00% 0.00% 0.00% 71.54%
Technology
0.00% 0.00% 15.59% 79.23%
Real Estate
0.00% 0.00% 6.65% 76.15%
Industrials
0.00% 0.00% 1.89% 73.85%
Financial Services
0.00% 0.00% 3.59% 77.69%
Energy
0.00% 0.00% 0.44% 72.31%
Communication Services
0.00% 0.00% 5.79% 75.38%
Consumer Defense
0.00% 0.00% 34.06% 72.31%
Consumer Cyclical
0.00% 0.00% 5.00% 75.38%
Basic Materials
0.00% 0.00% 2.08% 79.23%

Stock Geographic Breakdown

Weighting Return Low Return High HIAHX % Rank
US
81.50% 49.84% 100.00% 46.92%
Non US
17.41% 0.00% 42.53% 39.23%

Expenses

HIAHX - Expenses

Operational Fees

HIAHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.91% 0.10% 9.84% 78.74%
Management Fee 0.84% 0.09% 1.30% 66.92%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.40% 1.79%

Sales Fees

HIAHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

HIAHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HIAHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 42.00% 5.00% 341.00% 62.99%

Distributions

HIAHX - Distributions

Dividend Yield Analysis

HIAHX Category Low Category High HIAHX % Rank
Dividend Yield 0.00% 0.00% 6.04% 71.54%

Dividend Distribution Analysis

HIAHX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Net Income Ratio Analysis

HIAHX Category Low Category High HIAHX % Rank
Net Income Ratio 0.11% -2.24% 2.12% 34.65%

Capital Gain Distribution Analysis

HIAHX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

HIAHX - Fund Manager Analysis

Managers

Ann Gallo


Start Date

Tenure

Tenure Rank

May 01, 2000

19.93

19.9%

Ann C. Gallo, Senior Managing Director, and Global Industry Analyst of Wellington Management, joined as an investment professional in 1998. Prior to that, Ann was a health care analyst with BT Alex. Brown (1995 — 1998). She was an investment banker and a health care analyst at Piper Jaffray in Minneapolis (1992 — 1995). Previously, she was a financial analyst with Citibank N.A. (1991 — 1992) and an accountant with Coopers & Lybrand (1987 — 1989). Ann received her MS from the Massachusetts Institute of Technology and her BS in accounting from Boston College.

Jean Hynes


Start Date

Tenure

Tenure Rank

May 01, 2000

19.93

19.9%

Jean M. Hynes, CFA, Senior Managing Director and Global Industry Analyst of Wellington Management, has been involved in portfolio management and securities analysis for the health science portion of the Fund since August 2003. Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.

Robert Deresiewicz


Start Date

Tenure

Tenure Rank

May 01, 2000

19.93

19.9%

Robert L. Deresiewicz, Senior Managing Director, and Global Industry Analyst of Wellington Management, joined as an investment professional in 2000. Prior to that, Bob was an Assistant Professor of Medicine at the Harvard Medical School, and an Associate Physician in the Division of Infectious Diseases at the Brigham and Women's Hospital (1990 — 1998). Bob received his MBA from the Harvard Business School (2000), his MD from the Mount Sinai School of Medicine, and his BA in biochemistry summa cum laude from Columbia University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.18 22.56 10.01 19.93